Literature DB >> 25628396

Reply to "the brain, amphotericin B, and p-glycoprotein".

Ji-Qin Wu1, Kun Shao2, Chen Jiang2, Li-Ping Zhu3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25628396      PMCID： PMC4335890          DOI： 10.1128/AAC.04774-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  3 in total

1.  The brain, amphotericin B, and P-glycoprotein.

Authors:  David A Stevens; Karl V Clemons; Marife Martinez; Vicky Chen
Journal:  Antimicrob Agents Chemother       Date:  2015-02       Impact factor: 5.191

2.  In vitro and in vivo evidence for amphotericin B as a P-glycoprotein substrate on the blood-brain barrier.

Authors:  Ji-Qin Wu; Kun Shao; Xuan Wang; Rui-Ying Wang; Ya-Hui Cao; Yun-Qiu Yu; Jin-Ning Lou; Yan-Qiong Chen; Hua-Zhen Zhao; Qiang-Qiang Zhang; Xin-Hua Weng; Chen Jiang; Li-Ping Zhu
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

Review 3.  Three decades of P-gp inhibitors: skimming through several generations and scaffolds.

Authors:  A Palmeira; E Sousa; M H Vasconcelos; M M Pinto
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530
  3 in total
  1 in total

1.  Sensitive LC-MS/MS Methods for Amphotericin B Analysis in Cerebrospinal Fluid, Plasma, Plasma Ultrafiltrate, and Urine: Application to Clinical Pharmacokinetics.

Authors:  Leandro Francisco Pippa; Maria Paula Marques; Anna Christina Tojal da Silva; Fernando Crivelenti Vilar; Tissiana Marques de Haes; Benedito Antônio Lopes da Fonseca; Roberto Martinez; Eduardo Barbosa Coelho; Lauro Wichert-Ana; Vera Lucia Lanchote
Journal:  Front Chem       Date:  2021-11-29       Impact factor: 5.221
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.